𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comorbid disorders and hospitalisation in Parkinson’s disease: a prospective study

✍ Scribed by E. Martignoni; L. Godi; A. Citterio; R. Zangaglia; G. Riboldazzi; D. Calandrella; C. Pacchetti; G. Nappi


Book ID
106267824
Publisher
Springer Milan
Year
2004
Tongue
English
Weight
61 KB
Volume
25
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comorbid conditions associated with Park
✍ Cynthia L. Leibson; Demetrius M. Maraganore; James H. Bower; Jeanine E. Ransom; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract The burden of comorbidity in Parkinson's disease (PD) remains unclear. All Olmsted County, Minnesota, residents with incident PD in 1976–1995 (n = 197) plus one age‐ and sex‐matched non‐PD referent subject per case were followed for all clinical diagnoses from 5 years before through 15

Parkinson's syndrome and Parkinson's dis
✍ Josef Finsterer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract In the majority of cases, mitochondrial disorders are multisystem conditions that most frequently affect the skeletal muscle, followed by the central nervous system. One of the clinical manifestations of central nervous system involvement is Parkinson's syndrome (PS). Evidence for an as

Parkinson’s Disease and Nonmotor Dysfunc
✍ Pfeiffer, Ronald F.; Bodis-Wollner, Ivan 📂 Article 📅 2012 🏛 Humana Press 🌐 English ⚖ 184 KB

The first edition of Parkinson’s Disease and Nonmotor Dysfunction was published in 2005 to provide a source of detailed information that could be readily accessed by the practicing physician.  The widely praised first edition described and explained these nonmotor features that had at that point rec

Rate of clinical progression in Parkinso
✍ Anette Schrag; Richard Dodel; Annika Spottke; Bernhard Bornschein; Uwe Siebert; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate